Kunkel Lori Anne Insider Trading -- Recent SEC Form 4 Transactions
Kunkel Lori Anne (CIK 1536368) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-11-03). Recent activity: Buy ELVN (3,741 shares), Buy ELVN (7,300 shares), Sell ELVN (4,111 shares), Sell ELVN (5,889 shares), Sell ELVN (7,779 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Enliven Therapeutics, Inc. (ELVN) | Director | Buy | 3,741 | $4,190 |
| 2026-11-03 | Enliven Therapeutics, Inc. (ELVN) | Director | Buy | 7,300 | $133,590 |
| 2026-07-08 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 4,111 | $205,468 |
| 2026-07-08 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 5,889 | $299,397 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 7,779 | $266,664 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 1,867 | $66,017 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 354 | $12,680 |
| 2025-12-19 | Enliven Therapeutics, Inc. (ELVN) | Director | Buy | 15,958 | $17,873 |
| 2025-12-09 | Oric Pharmaceuticals, Inc. (ORIC) | Director | Buy | 10,000 | $79,000 |
| 2025-12-05 | Oric Pharmaceuticals, Inc. (ORIC) | Director | Buy | 5,534 | $20,752 |
Source: SEC Form 4 filings · as of 2026-11-03